Efficacy and safety of dual-targeted therapy for inflammatory bowel disease: a retrospective multicenter study in China
Background: Treatment options for patients with refractory inflammatory bowel disease (IBD) or concomitant IBD and extraintestinal manifestations (EIM) are often limited. Objective: This study aimed to examine the efficacy and safety of combining biologics or small molecules in patients with refract...
Saved in:
Main Authors: | Xiuxiu Jin, Kefang Sun, Liying Wang, Haiyan Shen, Dan Ma, Tejia Shen, Chunxiao Chen, Lan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/17562848241307598 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
by: Hongzhen Wu, et al.
Published: (2025-01-01) -
The Efficacy and Safety of Elobixibat for the Elderly with Chronic Constipation: A Multicenter Retrospective Cohort Study
by: Akira Tomie, et al.
Published: (2020-01-01) -
Novel Targets for Anti-Inflammatory Therapy in Inflammatory Bowel Disease
by: John L Wallace
Published: (1994-01-01) -
Effect of antithrombotic therapies on small bowel bleeding: an European multicenter retrospective study
by: Lucia Scaramella, et al.
Published: (2025-01-01) -
A retrospective multicenter study on the efficacy and safety of disitamab vedotin monotherapy versus combination with anti-PD-1 immunotherapy in advanced gastric cancer
by: Shuailei Dong, et al.
Published: (2025-01-01)